Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Sanofi-Aventis Stories

2012-02-08 06:00:00

PARIS, Feb. 8, 2012 /PRNewswire/ -- (Logo : http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Change at Change at Q4 2011 Change on a constant 2011 Change on a constant ------- ----------- --------- ---- ----------- --------- reported...

2012-02-07 13:04:00

BRIDGEWATER, N.J., Feb. 7, 2012 /PRNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Sklice® (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion, without nit combing. "The approval of Sklice Lotion provides physicians and parents with a new treatment option...

2012-01-26 10:26:00

PARSIPPANY, N.J., Jan. 26, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today confirmed that the United States Court of Appeals for the Federal Circuit has granted Watson and Amphastar Pharmaceuticals, Inc's request for a stay of the preliminary injunction preventing the companies from marketing or selling Amphastar's Enoxaparin Sodium Injection, a generic equivalent to Sanofi-aventis' LOVENOX®. The Federal Circuit's Order does not represent a final decision...

2012-01-22 08:00:00

Rehabmart.com, an online e-commerce company that sells rehabilitation and medical supplies, is proud to offer Chattem´s branded over-the-counter products and functional toiletries, some examples being Icy Hot ® and Gold Bond ®. Elberton, GA (PRWEB) January 22, 2012 Rehabmart.com, an online e-commerce company that sells rehabilitation and medical supplies, is proud to offer Chattem´s branded over-the-counter products and functional toiletries, some examples being Icy Hot...

2012-01-19 07:30:00

TUCSON, Ariz., Jan. 19, 2012 /PRNewswire/ -- The Catalina Council of the Boy Scouts of America announced today that approximately thirty Boy Scouts in Arizona will complete the Chemistry Merit Badge requirements through an event hosted by the Sanofi U.S. Research Center based in Oro Valley, Arizona. Boy Scout participants will have the chance to interact with leading healthcare industry biologists and chemists, under whose guidance they can participate in activities geared toward...

2012-01-18 19:30:00

CDISC ushers in the New Year with changes to its leadership. The addition of three highly qualified individuals to its board of directors will bring invaluable expertise to the CDISC organization for the term 2012 - 2015. Returning to the Board are Dr. C. David Hardison, and Dr. Pierre-Yves Lastic, joined by new board member Mr. Robert Goodwin. Each brings a unique skillset to the BoD to help guide CDISC as it moves forward with its goals and initiatives in 2012. Sincere appreciation goes to...

2012-01-10 09:00:00

SAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- The University of California, San Francisco (UCSF) has signed an alliance with international pharmaceutical company Sanofi (EURONEXT: SAN and NYSE: SNY) to share expertise in diabetes research and identify drug targets that could lead to new therapies for both type 1 and type 2 diabetes. The $3.1 million collaboration will bring together scientists in three UCSF labs with deep understanding of the biology of beta cells - insulin-producing cells...

2012-01-05 07:46:00

BRIDGEWATER, N.J., Jan. 5, 2012 /PRNewswire/ -- Sanofi US today announced that the U. S. District Court in Massachusetts granted the company a preliminary injunction against a Synvisc-One(®) (hylan G-F 20) competitor product developed by Seikagaku Corporation. The ruling allows for a restricted launch of Seikagaku's product prior to a scheduled trial date in April, and prohibits Seikagaku from selling their product below the current average sales price for Synvisc-One....

2012-01-05 07:00:00

CHICAGO and SWIFTWATER, Pa., Jan. 5, 2012 /PRNewswire/ -- The American Academy of Pediatrics (AAP) and Sanofi Pasteur announced today that pediatric offices across the country will now have access to a new vaccine packaging technology that will capture more product information in a simple two-dimensional (2D) scan - including lot numbers and expiration dates -- than was possible in a standard linear barcode scan. The new technology, which launched in December 2011, is...

2011-12-29 08:00:00

RARITAN, N.J., Dec. 29, 2011 /PRNewswire/ -- Janssen Research & Development, LLC (JRD) announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO(®) (rivaroxaban), an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular events in patients with Acute Coronary Syndrome (ACS). The filing is supported by data from the pivotal Phase 3 ATLAS ACS 2 TIMI 51 (Anti-Xa...